Zishen Pill alleviates diabetes in Db/db mice via activation of PI3K/AKT pathway in the liver

• Egile Nagusiak: You Wu (Egilea), Boju Sun (Egilea), Xiaoyuan Guo (Egilea), Lili Wu (Egilea), Yaomu Hu (Egilea), Lingling Qin (Egilea), Tao Yang (Egilea), Mei Li (Egilea), Tianyu Qin (Egilea), Miao Jiang (Egilea), Tonghua Liu (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The rising global incidence of type 2 diabetes mellitus (T2DM) highlights a need for new therapies. The Zishen Pill (ZSP) is a traditional Chinese herbal decoction that has previously shown hypoglycemic effects in C57BL/KsJ-db/db mice, although the therapeutic mechanism remains u...